Daratumumab activity in relapsed or primary refractory...

  • Main
  • 2019 / 05
  • Daratumumab activity in relapsed or primary refractory...

Daratumumab activity in relapsed or primary refractory systemic AL amyloidosis and Fcγ receptor 3A V158F polymorphisms

Xingguang Lee, Lisa, Zhou, Ping, Varga, Cindy, Fogaren, Teresa, Ho, Katelynn, Ma, Xun, Warner, Melissa, Toskic, Denis, Kugelmass, Adin, Comenzo, Raymond L.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Amyloid
DOI:
10.1080/13506129.2019.1600498
Date:
May, 2019
File:
PDF, 671 KB
2019
Conversion to is in progress
Conversion to is failed